1. Treatment and Prevention of Heparin-Induced Thrombocytopenia
Lori-Ann Linkins, MD, Antonio L. Dans, MD, Lisa K. Moores, MC, USA, FCCP, Robert Bona, MD, Bruce L. Davidson, MD, MPH, FCCP, Sam Schulman, MD, PhD, Mark Crowther, MD 
CHEST 
Volume 141, Issue 2, Pages e495S-e530S (February 2012)
DOI: /chest
Copyright © 2012 The American College of Chest Physicians Terms and Conditions

2. Figure 1
4Ts score. *Timing of clinical sequelae, such as thrombocytopenia, thrombosis, or skin lesions. **Two points if necrotizing heparin-induced skin lesions even if thrombocytopenia not present.
(Modified with permission from Warkentin and Linkins.59)
CHEST  , e495S-e530SDOI: ( /chest )
Copyright © 2012 The American College of Chest Physicians Terms and Conditions